REQUEST A DEMO
Total
USD $0.00
Search more companies

Igc Pharma Sas (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Igc Pharma Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Igc Pharma Sas is based in Colombia. The head office is in Bogota D.C.. It operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was incorporated on July 31, 2019. 26 (2024) employees currently work for Igc Pharma Sas. In 2023, the company reported a net sales revenue increase of 67.21%. Its total assets grew by 61.19% over the same period. The net profit margin of Igc Pharma Sas decreased by 1.46% in 2023.

Headquarters
Crr 19 A # 84 - 29 Edificio Grupo 7 Torre 7 Oficina 609
Bogota D.C.; Bogota D.C; Postal Code: 0813

Contact Details: Purchase the Igc Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Igc Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Igc Pharma Sas report to view the information.
Incorporation Date:
July 31, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Igc Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
67.21%
Total operating revenue
67.21%
Operating profit (EBIT)
156.2%
Net Profit (Loss) for the Period
32.48%
Total assets
61.19%
Total equity
57.53%
Operating Profit Margin (ROS)
3.6%
Net Profit Margin
-1.46%
Return on Equity (ROE)
-6.72%
Quick Ratio
-0.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?